Award of Contract Extension from AAH Pharmaceuticals
Quantum Pharma Plc (AIM:QP.), the growing, service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, is pleased to announce that Quantum Pharmaceutical Limited (“Quantum”), the largest business unit in the Group’s Specials division, has signed a new five-year contract extension with AAH Pharmaceuticals Limited (“AAH”). AAH is the UK’s leading wholesaler and distributor of pharmaceutical and healthcare products and services to pharmacy, hospitals and dispensing doctors. AAH is a division of Celesio UK which owns Lloyds Pharmacy and has a growing presence in the UK retail pharmacy sector.
Quantum is the UK's leading manufacturer and supplier of unlicensed medicines and special obtain products and has had a successful relationship with AAH since 2008. Under the terms of the new contract extension, Quantum will continue to be the exclusive supplier of specials1 and special obtains2 to AAH for the next five years, together with the provisions of certain order handling, procurement and distribution services in connection with such supply. AAH serves Lloyds Pharmacy and other pharmacies in the Celesio UK Group. Quantum will also provide outsourced third party management for AAH’s own specials offering, AAH Specials.
Andrew Scaife, Chief Executive of Quantum Pharma Plc, commented: “We are delighted to have signed this contract extension with AAH, a long term partner with whom Quantum has built a strong relationship.
“Not only is this partnership with AAH important for the Group financially, such strategic relationships with our Specials division also provide a further route to market for our licensed products and medical devices from our Niche Pharmaceutical division as well as potential partners for Biodose Connect® in our Medication Adherence division.
“We believe that no other specials supplier in the UK can rival what Quantum offers in relation to breadth of manufactured range, obtains procurement, capacity and delivery times; all backed by high levels of service and support.”
1 a special is an unlicensed medicine which is prescribed to a patient when the licensed form of a drug does not meet their specific clinical need, or when there is no licensed form of drug available on the market suitable to treat their condition. Specials are requested and prescribed for treatment by appropriately qualified doctors under their own authority.
2 a special obtain is a hard-to-source medicine or ancillary product that is not available from main pharmaceutical wholesalers, including specialist foods such as gluten-free breads, branded generics and vitamins, dressings, made-to-measure compression hosiery and dermatology products.
Posted by: Quantum Webmaster on 1st April 2016